Texas Oncology-McKinney — McKinney, Texas

Texas Oncology-McKinney is a clinical research site located in McKinney, Texas, United States 75071.

Crixeo Clinical Trials Trust Score: 22/100 (FAILING). This profile has not yet been claimed by the site owner.

Texas Oncology-McKinney has participated in 22 clinical trials with 11 currently active.

Therapeutic areas: Breast Neoplasm, Neoplasm Metastasis, Breast Cancer.

Sponsors: Eli Lilly and Company, Agendia, Pharmacyclics LLC..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in McKinney

Browse all research sites in Texas · View every site in McKinney

• Baylor Scott & White The Heart Hospital - Mckinney
• Research Site
• North Dallas Research Associates
• Metroplex Pulmonary and Sleep Center
• Texas Institute of Cardiology
• GSK Investigational Site
• Novartis Investigative Site
• Tekton Research
• ENT Associates of Texas
• Texas Institute of Cardiology PA
• North Texas Research Associates

Sponsor Feasibility Report

Trust Score: 22/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Texas Oncology-McKinney?

Texas Oncology-McKinney has a Crixeo Trust Score of 22/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Texas Oncology-McKinney conducted?

Texas Oncology-McKinney has 22 clinical trials on record, with 11 currently active. Their work covers Breast Neoplasm, Neoplasm Metastasis, Breast Cancer.

Is Texas Oncology-McKinney accredited by Crixeo Clinical Trials?

Texas Oncology-McKinney has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Texas Oncology-McKinney?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.